Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The Effect Of Hexarelin In Streptozotocin (STZ)-induced Rat Model Through Protective Actions On Islet Beta Cells And Cardiomyocytes

X. Zhang
Published 2015 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.2337/DIABETES.50.4.803
Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion?
N. Lameloise (2001)
Chronic Administration of Ghrelin Improves Left Ventricular Dysfunction and Attenuates Development of Cardiac Cachexia in Rats With Heart Failure
NoritoshiNagaya (2001)
10.1161/01.RES.0000106134.69300.B7
Angiotensin II Signaling Pathways Mediate Expression of Cardiac T-Type Calcium Channels
Laurent Ferron (2003)
10.1016/0168-8227(95)01144-7
Altered [Ca2+]i mobilization in diabetic cardiomyocytes: responses to caffeine, KCl, ouabain, and ATP.
J. Yu (1995)
10.1016/j.jep.2013.03.004
Antidiabetic activity of Ficus amplissima Smith. bark extract in streptozotocin induced diabetic rats.
K. Arunachalam (2013)
Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy.
C. Li (2009)
10.1055/s-0033-1341500
Adiponectin-induced inhibition of intrinsic and extrinsic apoptotic pathways protects pancreatic β-cells against apoptosis.
L. Jian (2013)
10.2337/diab.47.1.50
GLUT2 in Pancreatic Islets: Crucial Target Molecule in Diabetes Induced With Multiple Low Doses of Streptozotocin in Mice
Z. Wang (1998)
10.1210/JCEM.86.9.8002
A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans.
Y. Hataya (2001)
10.1093/CVR/24.5.381
Chronic diabetes mellitus prolongs action potential duration of rat ventricular muscles: circumstantial evidence for impaired Ca2+ channel.
S. Nobe (1990)
10.1046/j.1365-2826.2000.00416.x
Anatomically Specific Changes in the Expression of Somatostatin, Growth Hormone‐Releasing Hormone and Growth Hormone Receptor mRNA in Diabetic Rats
Busiguina (2000)
10.1016/S0092-8674(01)00378-6
Uncoupling Protein-2 Negatively Regulates Insulin Secretion and Is a Major Link between Obesity, β Cell Dysfunction, and Type 2 Diabetes
C. Zhang (2001)
10.1152/PHYSREV.1999.79.1.215
Molecular mechanisms of myocardial remodeling.
B. Swynghedauw (1999)
10.1152/AJPHEART.00193.2004
Ghrelin induces vasoconstriction in the rat coronary vasculature without altering cardiac peptide secretion.
C. Pemberton (2004)
10.1016/0022-2828(92)93197-R
Cytosolic Ca2+ concentration and pH of diabetic rat myocytes during metabolic inhibition.
Naoko Noda (1992)
10.1210/EN.2002-220783
The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis.
Kichoon Choi (2003)
10.1093/CVR/26.4.409
Mitochondrial dysfunction observed in situ in cardiomyocytes of rats in experimental diabetes.
Y. Tanaka (1992)
10.1152/AJPHEART.1996.271.5.H2190
Metabolic basis of decreased transient outward K+ current in ventricular myocytes from diabetic rats.
Z. Xu (1996)
10.1002/j.1460-2075.1993.tb05949.x
Heterogeneity in glucose sensitivity among pancreatic beta‐cells is correlated to differences in glucose phosphorylation rather than glucose transport.
H. Heimberg (1993)
10.1046/j.1440-1681.2002.03618.x
A Metabolic Mechanism For Cardiac K+ Channel Remodelling
G. Rozanski (2002)
10.1046/j.1365-2265.1997.2901107.x
Abnormal pulsatile secretion of growth hormone in non‐insulin‐dependent diabetes mellitus
E. Franek (1997)
10.1126/science.273.5277.974
A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release
A. Howard (1996)
10.1016/j.ejheart.2006.03.001
Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions
A. van den Bergh (2006)
10.1152/ajpendo.90352.2008
Proteomic changes associated with diabetes in the BB-DP rat.
D. Johnson (2009)
10.1023/A:1006827907631
Fura-2 fluorescent technique for the assessment of Ca2+ homeostasis in cardiomyocytes
Yan-Jun Xu (2004)
Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion.
Y. Date (2002)
10.1083/jcb.200207165
Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT
G. Baldanzi (2002)
10.1161/01.CIR.0000127956.43874.F2
Ghrelin Inhibits Proinflammatory Responses and Nuclear Factor-κB Activation in Human Endothelial Cells
W. Li (2004)
Redox regulation of Ito remodeling in diabetic rat heart
X Li (2005)
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus
DeFronzo (1985)
10.1210/EN.2005-0938
Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.
J. Buchanan (2005)
10.1074/jbc.274.39.27905
Hydrogen Peroxide Alters Mitochondrial Activation and Insulin Secretion in Pancreatic Beta Cells*
P. Maechler (1999)
10.2337/db11-0809
Increased Phagocyte-Like NADPH Oxidase and ROS Generation in Type 2 Diabetic ZDF Rat and Human Islets
I. Syed (2011)
10.1016/S0140-6736(63)91500-9
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.
P. Randle (1963)
10.2337/DIABETES.55.03.06.DB05-1284
Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice.
L. Pereira (2006)
10.1186/1475-2840-9-3
Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease
C. Andersson (2010)
[Endocrine glands of pancreas].
Tadao Iburi (2011)
10.1007/BF03345618
Feeding behavior during long-term hexarelin administration in young and old rats
E. Bresciani (2008)
10.2337/db07-0481
Mitochondrial Energetics in the Heart in Obesity-Related Diabetes
S. Boudina (2007)
10.1016/S0002-9149(00)01366-7
Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus.
M. Zabalgoitia (2001)
Ghrelin--a hormone with multiple functions.
M. Korbonits (2004)
10.1152/AJPHEART.01042.2004
GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure.
X. Xu (2005)
10.1006/JMCC.2000.1107
Diminished expression of sarcoplasmic reticulum Ca(2+)-ATPase and ryanodine sensitive Ca(2+)Channel mRNA in streptozotocin-induced diabetic rat heart.
Y. Teshima (2000)
10.2337/DIABETES.52.3.777
Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production.
Gang Ye (2003)
10.2337/db09-0259
Tissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice
H. Bugger (2009)
10.1210/ENDO.134.1.7903934
Acute effects of hypoglycemia and hyperglycemia on hypothalamic growth hormone-releasing hormone and somatostatin gene expression in the rat.
K. Murao (1994)
10.1007/BF00277478
Impairment of diastolic function in middle-aged Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease
M. Uusitupa (2004)
10.1042/BJ1910421
Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria.
J. Turrens (1980)
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).
J. Lehmann (1995)
10.1042/CS20070166
Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome.
H. Bugger (2008)
10.1152/AJPREGU.2001.281.6.R1975
Impact of pulsatility on the ensemble orderliness (approximate entropy) of neurohormone secretion.
J. Veldhuis (2001)
Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents
池崎 綾子 (2006)
10.1006/JMCC.2002.2061
Peroxisome Proliferator-activated Receptor α (PPARα) Signaling in the Gene Regulatory Control of Energy Metabolism in the Normal and Diseased Heart
B. Finck (2002)
10.1016/S0735-1097(02)02869-3
Echocardiographic detection of early diabetic myocardial disease.
Z. Fang (2003)
10.1038/labinvest.3780057
Myocyte Death in Streptozotocin-Induced Diabetes in Rats Is Angiotensin II- Dependent
F. Fiordaliso (2000)
10.1080/07853890252953491
Ghrelin, growth and obesity
O. Ukkola (2002)
10.1172/JCI106364
Abnormal serum growth hormone response to exercise in juvenile diabetics.
A. P. Hansen (1970)
10.1007/BF02913315
Induction of diabetes by Streptozotocin in rats
A. Akbarzadeh (2008)
10.1152/AJPCELL.1991.260.6.C1165
Non-insulin-dependent diabetes-induced defects in cardiac cellular calcium regulation.
S. Allo (1991)
10.1210/JCEM.85.12.7167
Ghrelin strongly stimulates growth hormone release in humans.
K. Takaya (2000)
10.1146/ANNUREV.BB.18.060189.002001
Biochemistry and biophysics of excitation-contraction coupling.
S. Fleischer (1989)
10.1210/JCEM.83.4.4711
Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation.
N. Pandya (1998)
Abplanalp, Resistance of growth hormone secretion to somatostatin in men with type I diabetes mellitus
R. M. Cohen (1991)
Effects of gender difference on cardiac myocyte dysfunction in streptozotocin-induced diabetic rats
Ding (2006)
10.1161/01.RES.85.10.919
Regulation of sarcolemmal Na(+)/H(+) exchanger activity by angiotensin II in adult rat ventricular myocytes: opposing actions via AT(1) versus AT(2) receptors.
S. Gunasegaram (1999)
Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats.
K. M. Choi (2002)
10.3109/00365517109086892
Free fatty acids and oxygen consumption in dogs.
O. Mjös (1971)
10.2337/dc10-0770
Association Between Serum IGF-1 and Diabetes Among U.S. Adults
S. Teppala (2010)
10.2337/DIABETES.47.3.307
Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities.
F. Matschinsky (1998)
10.1152/ajpheart.00165.2009
Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus.
T. Radovits (2009)
10.1113/jphysiol.2008.155317
Novel aspects of the molecular mechanisms controlling insulin secretion
L. Eliasson (2008)
10.1161/01.CIR.100.8.813
Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus.
M. D. Di Carli (1999)
10.1210/ER.2002-0029
Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin.
A. J. van der Lely (2004)
10.1016/S0008-6363(97)00034-5
Intracellular calcium levels are unchanged in the diabetic heart.
J. Yu (1997)
10.1210/ENDO-120-4-1658
The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II.
G. Ceda (1987)
10.1101/GAD.13.15.1899
BCL-2 family members and the mitochondria in apoptosis.
A. Gross (1999)
10.1016/j.cmet.2009.02.007
Insulin signaling in alpha cells modulates glucagon secretion in vivo.
D. Kawamori (2009)
10.1210/ENDO.138.2.4907
Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6.
S. Dickson (1997)
10.1161/HC0302.102143
Decreased Cardiac Expression of Vascular Endothelial Growth Factor and Its Receptors in Insulin-Resistant and Diabetic States: A Possible Explanation for Impaired Collateral Formation in Cardiac Tissue
E. Chou (2002)
10.1016/S0014-2999(99)00537-3
Cardiac effects of hexarelin in hypopituitary adults.
G. Bisi (1999)
10.2337/db06-0129
Granzyme B–Mediated Death of Pancreatic β-Cells Requires the Proapoptotic BH3-Only Molecule Bid
E. Estella (2006)
10.1007/s00380-006-0962-9
Increased prevalence of ventricular fibrillation in patients with type 2 diabetes mellitus
M. Movahed (2006)
10.1152/AJPHEART.1996.271.1.H192
Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart.
C. E. Flarsheim (1996)
10.1046/j.1365-2826.2000.00584.x
Systemic Administration of Ghrelin Induces Fos and Egr‐1 Proteins in the Hypothalamic Arcuate Nucleus of Fasted and Fed Rats
A. Hewson (2000)
10.1007/BF01745169
Expression of vascular endothelial growth factor in human myocardial infarction
Kaoru Shinohara (2005)
10.1152/AJPHEART.01122.2002
Effect of NO synthase inhibition on myocardial metabolism during moderate ischemia.
C. Martin (2003)
10.1007/s12020-009-9275-y
Cholesterol induces mitochondrial dysfunction and apoptosis in mouse pancreatic beta-cell line MIN6 cells
Yu-feng Zhao (2009)
10.1161/01.HYP.0000082814.62655.85
AT1 Blockade Prevents Glucose-Induced Cardiac Dysfunction in Ventricular Myocytes: Role of the AT1 Receptor and NADPH Oxidase
Jamie R Privratsky (2003)
10.1126/SCIENCE.275.5303.1132
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
R. Kluck (1997)
10.1016/j.tem.2005.11.004
Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system
J. Cao (2006)
10.1016/J.BIOCEL.2005.12.006
In beta-cells, mitochondria integrate and generate metabolic signals controlling insulin secretion.
P. Maechler (2006)
10.1016/s0021-9258(17)46660-9
Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow.
G. Ambrosio (1993)
Sonnenblick, Diabetic cardiomyopathy
F. S. Fein (1994)
10.1210/JCEM-53-6-1148
Growth hormone and somatomedin in insulin-dependent diabetes mellitus.
J. Horner (1981)
10.1097/00005344-200402000-00001
Protective Effects of Ghrelin on Ischemia/Reperfusion Injury in the Isolated Rat Heart
L. Chang (2004)
10.1210/ENDO-108-1-76
Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin.
G. Tannenbaum (1981)
Altered growth hormone (GH) secretion in vivo and in vitro in the diabetes-prone BB/Worcester rat.
F. Nieves-Rivera (1993)
10.1016/S0140-6736(64)90515-X
THE GROWTH-HORMONE-DEPENDENT SULPHATION FACTOR IN SERUM OF UNTREATED DIABETICS.
H. Yde (1964)
10.2337/DIABETES.54.SUPPL_2.S97
Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.
M. Cnop (2005)
Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.
R. Robertson (2004)
10.1161/01.RES.87.11.1026
Role of the Calcium-Independent Transient Outward Current Ito1 in Shaping Action Potential Morphology and Duration
J. L. Greenstein (2000)
10.1016/0002-9149(74)90089-7
Role of diabetes in congestive heart failure: the Framingham study.
W. Kannel (1974)
10.1007/s00125-012-2822-8
Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model
M. Jiménez-González (2012)
10.1172/JCI115014
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.
R. Bucala (1991)
10.1038/nm.3482
MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes
A. Ardestani (2014)
10.1210/EN.2002-220819
Dose-dependent inhibition by ghrelin of insulin secretion in the mouse.
M. Reimer (2003)
10.1016/S1525-2167(03)90774-8
Cardiac lipid accumulation associated with diastolic dysfunction in obese mice.
C. Christoffersen (2003)
10.1530/EJE.0.1460241
Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion.
E. M. Egido (2002)
10.1210/ENDO.135.3.7915227
Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep.
V. Guillaume (1994)
10.1152/AJPENDO.1989.256.1.E25
Basis for myocardial mechanical defects associated with non-insulin-dependent diabetes.
S. Schaffer (1989)
10.1210/en.2009-0877
Growth hormone secretagogues reduce transient outward K+ current via phospholipase C/protein kinase C signaling pathway in rat ventricular myocytes.
Qiang Sun (2010)
10.1152/PHYSIOL.00008.2006
Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes.
S. Boudina (2006)
10.2337/diab.32.9.781
Defective Oxidative Metabolism of Heart Mitochondria from Genetically Diabetic Mice
T. Kuo (1983)
10.1046/j.1365-2826.2002.00811.x
Ghrelin Stimulates Insulin Secretion from the Pancreas of Normal and Diabetic Rats
E. Adeghate (2002)
10.1161/CIRCULATIONAHA.106.662296
Insulin-Resistant Heart Exhibits a Mitochondrial Biogenic Response Driven by the Peroxisome Proliferator-Activated Receptor-&agr;/PGC-1&agr; Gene Regulatory Pathway
J. Duncan (2007)
10.2337/diacare.12.2.159
Augmentation of Atrial Contribution to Left Ventricular Filling in IDDM Subjects as Assessed by Doppler Echocardiography
K. Airaksinen (1989)
10.1016/s0021-9258(17)37629-9
Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing.
N. Sekine (1994)
Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy
X Shen (2006)
Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome
X Liu (1996)
10.1016/0026-0495(89)90224-2
Glucocorticoid effects on IGF-1/somatomedin-C and somatomedin inhibitor in streptozotocin-diabetic rats.
J. Hofert (1989)
Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).
T. Aoyama (1998)
10.1093/acprof:oso/9780195058239.001.0001
Bioelectromagnetism: Principles and Applications of Bioelectric and Biomagnetic Fields
J. Malmivuo (1995)
Redox regulation of I-to remodeling in diabetic rat heart
X Li (2005)
10.1007/s00018-008-8322-9
Molecular Physiology of Mammalian Glucokinase
P. Iynedjian (2008)
10.1210/JCEM.86.4.7402
Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines.
P. Cassoni (2001)
10.2337/DIABETES.50.6.1414
IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress.
J. Kajstura (2001)
10.1007/BF03343555
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans
G. Bisi (1999)
10.1139/y99-101
Effects of diabetes and hypertension on myocardial Na+-Ca2+ exchange.
H. Kashihara (2000)
10.1074/jbc.273.10.5678
Altered Constitutive Expression of Fatty Acid-metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor α (PPARα)*
T. Aoyama (1998)
10.1016/0022-2828(81)90296-0
Cardiac myofibrillar ATPase activity in diabetic rats.
G. Pierce (1981)
10.2337/diab.34.2.156
Impaired Somatomedin Generation Test in Children with Insulin-dependent Diabetes Mellitus
R. Lanes (1985)
Grisham, Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations
M. M. Tarpey (2004)
10.1074/JBC.R200006200
The Key Role of Anaplerosis and Cataplerosis for Citric Acid Cycle Function*
O. Owen (2002)
Sonnenblick, DIABETIC CARDIOMYOPATHY
F. S. Fein (1985)
10.2337/DIABETES.53.2007.S119
β-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes
R. Robertson (2004)
10.1007/s00125-006-0226-3
Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats
T. Irako (2006)
10.2337/diab.40.10.1251
Resistance of Growth Hormone Secretion to Somatostatin in Men With Type I Diabetes Mellitus
R. Cohen (1991)
10.1159/000123472
Influence of streptozotocin-induced diabetes on growth hormone secretion in the rat.
M. Bluet-Pajot (1983)
10.1042/BST0181125
Insulin action on glucose transport in isolated cardiac myocytes: signalling pathways and diabetes-induced alterations.
J. Eckel (1990)
10.1046/J.1432-1327.1998.2520001.X
Mitochondria and apoptosis.
B. Mignotte (1998)
10.1016/S0024-3205(98)00287-2
Differences in regional distribution of K+ current densities in rat ventricle.
O. Casis (1998)
Paracrine functions of somatomedins.
L. Underwood (1986)
10.1126/SCIENCE.275.5303.1129
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
J. Yang (1997)
10.1152/ajpregu.00477.2010
Analytical construct of reversible desensitization of pituitary-testicular signaling: illustrative application in aging.
D. Keenan (2011)
10.1210/JCEM-69-2-239
Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus.
C. Asplin (1989)
10.1016/S0092-8674(03)00116-8
Mitochondria Releasing Power for Life and Unleashing the Machineries of Death
D. Newmeyer (2003)
10.1007/s12020-009-9243-6
Serum heart type fatty acid binding protein levels in metabolic syndrome
E. Akbal (2009)
10.1007/s00395-007-0691-y
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening
G. Bhamra (2007)
10.1152/AJPHEART.00824.2006
Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade.
N. Yaraş (2007)
10.1159/000124814
Growth hormone responsiveness in vivo and in vitro to growth hormone releasing factor in the spontaneously diabetic BB Wistar rat.
O. Serri (1987)
10.1152/AJPHEART.1994.266.6.H2334
Depressed [Ca2+]i responses to isoproterenol and cAMP in isolated cardiomyocytes from experimental diabetic rats.
Z. Yu (1994)
Overexpression of intraislet ghrelin enhances beta-cell proliferation after streptozotocin-induced beta-cell injury in mice
M Bando (2013)
10.1073/PNAS.95.4.1455
Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux.
S. Shimizu (1998)
10.1016/S0039-6109(05)70141-9
Islet cell tumors of the pancreas: the medical oncologist's perspective.
R. Brentjens (2001)
Streptozotocin-induced experimental diabetes in male Wistar rats.
A. Gajdošík (1999)
10.1152/AJPHEART.1991.261.4.H1086
Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta.
Y. Hattori (1991)
10.3109/08977194.2010.504721
Reg2 protects mouse insulinoma cells from streptozotocin-induced mitochondrial disruption and apoptosis
L. Liu (2010)
10.1161/01.RES.82.4.407
Cardiac physiology in transgenic mice.
J. James (1998)
10.1161/01.CIR.0000127959.28627.F8
Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women
L. R. Peterson (2004)
10.1038/ijo.2009.97
The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes
T. Wilkin (2009)
Boveris, Hydroperoxide metabolism in mammalian organs
B. Chance (1979)
10.1016/J.ECL.2006.05.002
Alterations in ion channel physiology in diabetic cardiomyopathy.
D. Cesario (2006)
10.1016/J.METABOL.2006.06.022
Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
L. Li (2006)
10.1016/S0014-2999(02)01934-9
Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery.
F. Broglio (2002)
10.1053/META.2002.35200
Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress.
S. Piro (2002)
10.1111/J.1525-1373.1999.09997.PP.X
Administration of a nonpeptidyl growth hormone secretagogue, L-163, 255, changes somatostatin pattern, but has no effect on patterns of growth hormone-releasing factor in the hypophyseal-portal circulation of the conscious pig.
J. Drisko (1999)
10.1172/JCI118747
Apoptosis in pressure overload-induced heart hypertrophy in the rat.
E. Teiger (1996)
10.1210/EDRV.19.6.0353
Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.
A. Giustina (1998)
10.1210/en.2012-1404
Growth hormone secretagogues preserve the electrophysiological properties of mouse cardiomyocytes isolated from in vitro ischemia/reperfusion heart.
Y. Ma (2012)
10.1161/HC1002.105185
Progression of Systolic Abnormalities in Patients With “Isolated” Diastolic Heart Failure and Diastolic Dysfunction
C. Yu (2002)
10.1210/EN.2006-0266
Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling.
R. Granata (2007)
10.2337/db11-0786
In Situ Electrophysiological Examination of Pancreatic α Cells in the Streptozotocin-Induced Diabetes Model, Revealing the Cellular Basis of Glucagon Hypersecretion
Y. Huang (2013)
Boveris, Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria
J. F. Turrens (1980)
10.1161/01.RES.54.2.144
A Comparison of Calcium Currents in Rat and Guinea Pig Single Ventricular Cells
I. Josephson (1984)
10.1210/ME.2006-0146
A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
R. Avallone (2006)
10.1111/J.1432-1033.1996.0001U.X
A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs.
K. Lambe (1996)
10.2337/DIABETES.51.11.3211
Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet.
J. Joseph (2002)
Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart Failure
NoritoshiNagaya (2004)
10.1172/JCI108843
Evidence for cardiomyopathy in familial diabetes mellitus.
T. Regan (1977)
10.1074/jbc.274.1.305
Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase*
C. Postic (1999)
10.1210/JCEM-60-6-1204
Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin.
G. Ceda (1985)
10.1210/ENDO-115-6-2227
Diurnal variations of plasma growth hormone, thyrotropin, thyroxine, and triiodothyronine in streptozotocin-diabetic and food-restricted rats.
J. Ortiz-Caro (1984)
10.1152/AJPHEART.00313.2002
Defective intracellular Ca2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats
K. M. Choi (2002)
10.1056/NEJM198108063050602
Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels.
W. Tamborlane (1981)
10.1161/01.RES.0000117088.36577.EB
Cardiac-Specific Induction of the Transcriptional Coactivator Peroxisome Proliferator-Activated Receptor &ggr; Coactivator-1&agr; Promotes Mitochondrial Biogenesis and Reversible Cardiomyopathy in a Developmental Stage-Dependent Manner
Laurie K. Russell (2004)
10.2337/diab.40.12.1645
Decreased Incorporation of Long-Chain Fatty Acids into Erythrocyte Phospholipids of STZ-D Rats
A. Dang (1991)
10.1097/00075197-200207000-00007
Ghrelin: a novel peptide for growth hormone release and feeding regulation
F. Yoshihara (2002)
10.1016/0006-8993(85)91469-6
Effect of growth hormone-releasing stimuli in streptozotocin diabetic rats
V. Locatelli (1985)
10.1210/en.2013-1291
Hexarelin treatment in male ghrelin knockout mice after myocardial infarction.
Y. Mao (2013)
10.1159/000185015
Growth hormone-releasing peptides: clinical and basic aspects.
J. Argente (1996)
10.1016/0002-9149(81)90732-3
Reversibility of Diabetic Cardiomyopathy with Insulin in Rats
F. Fein (1981)
10.1002/CLC.4960200606
Isolated and preclinical impairment of left ventricular filling in insulin‐dependent and non‐insulin‐dependent diabetic patients
E. Astorri (1997)
10.1074/JBC.270.22.12953
An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*)
J. Lehmann (1995)
Evidence for a role of superoxide generation in glucose-induced beta-cell dysfunction in vivo
C Tang (2007)
10.1155/EDR.2003.73
Growth Hormone (GH) Hypersecretion and GH Receptor Resistance in Streptozotocin Diabetic Mice in Response to a GH Secretagogue
P. Johansen (2003)
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
G. Grynkiewicz (1985)
10.1152/physrev.00039.2007
Designing heart performance by gene transfer.
Jennifer Davis (2008)
10.1111/j.1365-2265.1993.tb00987.x
Cholinergic control of growth hormone (GH) responses to GH‐releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback
I. Ismail (1993)
10.1126/SCIENCE.1104343
Mitochondrial Dysfunction and Type 2 Diabetes
B. Lowell (2005)
10.1113/jphysiol.2003.055590
Gender‐dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice
Y. Shimoni (2004)
10.1007/BF03347409
Endogenous ghrelin increases in adriamycin-induced heart failure rats
Z. Xu (2007)
10.2337/DIABETES.51.6.1938
Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway.
L. Cai (2002)
10.1210/ENDO.139.10.6330
Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus.
G. Tannenbaum (1998)
10.1016/j.fct.2013.11.013
Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
X. Sun (2014)
10.1016/J.AMJCARD.2003.12.026
Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.
J. Boyer (2004)
10.1210/en.2011-0253
Development of a method for the determination of pulsatile growth hormone secretion in mice.
F. Steyn (2011)
Poykko, Ghrelin, growth and obesity
O. Ukkola (2002)
10.1038/45230
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
M. Kojima (1999)
10.1152/AJPHEART.1994.266.5.H2082
Cellular functions of diabetic cardiomyocytes: contractility, rapid-cooling contracture, and ryanodine binding.
Z. Yu (1994)
10.1186/1475-2840-11-129
Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms
M. Aragno (2012)
10.1530/JME-13-0122
The islet ghrelin cell.
N. Wierup (2014)
10.1152/AJPHEART.00648.2003
Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro.
Jin-Jiang Pang (2004)
10.1089/jmf.2012.2480
Mangiferin from Salacia chinensis prevents oxidative stress and protects pancreatic β-cells in streptozotocin-induced diabetic rats.
Periyar selvam Sellamuthu (2013)
10.1006/BBRC.2001.4825
Downregulation of K(+) channel genes expression in type I diabetic cardiomyopathy.
D. Qin (2001)
10.1210/EN.2002-220670
Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
S. R. Cunha (2002)
10.2337/DIABETES.50.6.1290
High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program.
M. Federici (2001)
10.1007/s00125-012-2466-8
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans
J. Meier (2012)
10.1007/BF01745095
Rate-Dependent prolongation of action potential duration in single ventricular myocytes obtained from hearts of rats with streptozotocin-induced chronic diabetes sustained for 30–32 weeks
S. Shigematsu (2005)
10.1172/JCI109069
Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia.
S. Bhathena (1978)
10.1111/j.1469-7793.1999.735ad.x
Insulin stimulation of rat ventricular K+ currents depends on the integrity of the cytoskeleton
Y. Shimoni (1999)
10.1007/BF00425888
Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics
A. P. Hansen (2004)
10.1210/JCEM.84.3.5523
Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency.
H. Maheshwari (1999)
10.1006/JMCC.1996.0002
Stimulation of the Na+/Ca2+ exchanger by phenylephrine, angiotensin II and endothelin 1.
C. Ballard (1996)
10.1016/j.tox.2008.02.018
Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-kappaB pathways and mitochondrial protective mechanisms.
Z. Xu (2008)
10.1016/S0735-1097(86)80150-4
Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy.
J. Kahn (1986)
10.1113/jphysiol.2004.074161
Effects of gestational age and cortisol treatment on ovine fetal heart function in a novel biventricular Langendorff preparation
A. J. Fletcher (2005)
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.
T. Szkudelski (2001)
10.1210/JCEM.83.5.4812
Growth hormone status during long-term hexarelin therapy.
A. Rahim (1998)
10.1152/AJPENDO.00255.2001
Reduced activity of mtTFA decreases the transcription in mitochondria isolated from diabetic rat heart.
A. Kanazawa (2002)
10.1152/AJPHEART.00856.2006
Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse.
Patrick Yue (2007)
10.1016/S0092-8674(00)80085-9
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
X. Liu (1996)
10.1016/S0140-6736(11)60679-X
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
G. Danaei (2011)
10.1385/ENDO:14:1:021
Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin
G. Tannenbaum (2007)
10.1126/SCIENCE.6262917
Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary.
M. Berelowitz (1981)
10.1007/BF03346307
Ghrelin improves growth hormone responses to growth hormone-releasing hormone in a streptozotocin-diabetic model of delayed onset
Y. Diz-Chaves (2007)
10.1152/AJPHEART.00004.2007
Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat.
Xiangbin Xu (2007)
10.1084/JEM.192.10.1403
Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, but Not Direct Granzyme B–Mediated Caspase Activation
V. Sutton (2000)
10.1152/AJPENDO.1988.254.1.E23
Lowering of plasma glucose in diabetic rats by antilipolytic agents.
G. Reaven (1988)
10.1161/01.CIR.0000149746.62908.BB
Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart Failure
N. Nagaya (2004)
10.2337/db07-0279
Evidence for a Role of Superoxide Generation in Glucose-Induced β-Cell Dysfunction In Vivo
C. Tang (2007)
10.1042/BST20060243
K(ATP) channels and insulin secretion: a key role in health and disease.
F. Ashcroft (2006)
10.1161/01.RES.0000016164.02525.B4
CD36 Mediates the Cardiovascular Action of Growth Hormone-Releasing Peptides in the Heart
V. Bodart (2002)
10.1016/S0014-5793(03)01233-X
Enhanced permeability transition explains the reduced calcium uptake in cardiac mitochondria from streptozotocin‐induced diabetic rats
P. Oliveira (2003)
10.2337/DIABETES.51.1.124
Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion
Y. Date (2002)
10.1016/S0300-595X(86)80042-1
3 Paracrine functions of somatomedins
L. Underwood (1986)
10.2337/diab.33.12.1175
Effect of Diabetes and its Control on Insulin-like Growth Factors in the Young Subject with Type I Diabetes
S. Amiel (1984)
10.1172/JCI112832
Insulinlike growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells.
S. Yamashita (1987)
10.1073/PNAS.95.25.14681
Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria.
M. Narita (1998)
10.1046/J.1529-8027.2001.01008-3.X
Induction Of Endothelin‐1 Expression By Glucose: An Effect Of Protein Kinase C Activation
J. Park (2001)
10.1101/pdb.prot4986
Hematoxylin and eosin staining of tissue and cell sections.
A. Fischer (2008)
10.1210/ENDO-126-1-53
Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
D. Olchovsky (1990)
10.2337/DIABETES.52.10.2546
Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes.
S. Pöykkö (2003)
10.1152/AJPHEART.1986.250.1.H108
Reversibility of diabetic cardiomyopathy with insulin in rabbits.
F. Fein (1986)
10.1074/jbc.M303734200
Protein Tyrosine Nitration in the Mitochondria from Diabetic Mouse Heart
I. Turko (2003)
Developmental biology of the pancreas.
J. Slack (1995)
10.1385/ENDO:25:2:073
Diabetic cardiomyopathy
J. Ren (2007)
10.1007/s00125-011-2365-4
Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice
Y. Takeda (2011)
10.1016/J.JTBI.2005.03.008
Composite model of time-varying appearance and disappearance of neurohormone pulse signals in blood.
D. Keenan (2005)
10.1074/JBC.271.9.4573
Molecular Ordering of the Cell Death Pathway
A. Chinnaiyan (1996)
10.1016/j.tem.2012.06.002
Mitochondrial dysfunction in pancreatic β cells
Sachin Supale (2012)
10.1016/S0014-5793(03)00306-5
Enhanced plasma ghrelin levels in rats with streptozotocin‐induced diabetes
T. Masaoka (2003)
Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart.
B. Finck (2002)
10.1016/J.RDC.2004.10.006
Growth hormone/insulin-like growth factor-I system and connective tissues: basic aspects and clinical implications.
A. Colao (2005)
10.2337/DIABETES.53.12.3201
Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart.
D. Belke (2004)
10.1016/S0968-0004(00)01674-1
Mitochondria, oxygen free radicals, disease and ageing.
S. Raha (2000)
Sonnenblick, Diabetic cardiomyopathy
F. S. Fein (1994)
10.2337/db08-0140
Altered Calcium Homeostasis Does Not Explain the Contractile Deficit of Diabetic Cardiomyopathy
L. Zhang (2008)
10.1152/physrev.00017.2007
Cardiac remodeling in obesity.
E. Abel (2008)
10.1152/AJPHEART.1983.245.6.H969
Cardiac sarcoplasmic reticulum function in insulin- or carnitine-treated diabetic rats.
G. Lopaschuk (1983)
10.1172/JCI111938
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.
R. DeFronzo (1985)
10.1152/AJPREGU.00361.2003
Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations.
M. Tarpey (2004)
10.1016/0002-9149(91)90716-X
Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study).
M. Galderisi (1991)
The islets of Langerhans. Preface.
M. S. Islam (2010)
10.1016/J.AHJ.2004.06.021
Screening for heart disease in diabetic subjects.
Z. Fang (2005)
Effect of streptozotocin diabetes on fatty acid content and composition of the heart lipids in the rat.
A. Nawrocki (1999)
10.1007/s12672-010-0047-1
Expression and In Vitro Functions of the Ghrelin Axis in Endometrial Cancer
J. N. Fung (2010)
10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation
K. Alberti (1998)
10.1016/S0891-5849(03)00142-4
Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide.
H. Zhao (2003)
10.1210/me.2011-1001
Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells.
Jen-Chieh Chuang (2011)
10.1074/JBC.M303139200
Quantitative Protein Profiling in Heart Mitochondria from Diabetic Rats*
I. Turko (2003)
Type 1 diabetes: molecular, cellular and clinical immunology.
G. Eisenbarth (2004)
10.1016/S0168-8227(11)70009-2
The role of α-, δ- and F cells in insulin secretion and action.
John G Youos (2011)
Nesto, DIABETIC CARDIOMYOPATHY
S. W. Zarich (1989)
Matlib, Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart
C. E. Flarsheim (1996)
10.1161/01.CIR.0000162472.52990.36
Progressive Attenuation of Myocardial Vascular Endothelial Growth Factor Expression Is a Seminal Event in Diabetic Cardiomyopathy: Restoration of Microvascular Homeostasis and Recovery of Cardiac Function in Diabetic Cardiomyopathy After Replenishment of Local Vascular Endothelial Growth Factor
Y. Yoon (2005)
10.1152/AJPHEART.00278.2006
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy.
D. An (2006)
10.1161/CIRCRESAHA.109.199810
Interval Training Normalizes Cardiomyocyte Function, Diastolic Ca2+ Control, and SR Ca2+ Release Synchronicity in a Mouse Model of Diabetic Cardiomyopathy
T. Stølen (2009)
10.2337/DIABETES.53.12.3142
Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents.
K. Dezaki (2004)
Abplanalp, Resistance of growth hormone secretion to somatostatin in men with type I diabetes mellitus
R. M. Cohen (1991)
10.1007/s10541-005-0102-7
Mitochondrial metabolism of reactive oxygen species
A. Andreyev (2005)
10.1038/35008121
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T. Nishikawa (2000)
10.1074/JBC.273.51.33905
The Changes in Adenine Nucleotides Measured in Glucose-stimulated Rodent Islets Occur in β Cells but Not in α Cells and Are Also Observed in Human Islets*
P. Detimary (1998)
10.1002/0470868694.CH20
A mitochondrial paradigm for degenerative diseases and ageing.
D. Wallace (2001)
[Somatomedin inhibition of the growth hormone secretion stimulated by the hypothalamic factor somatocrinin or the synthetic peptide hpGRF].
P. Brazeau (1982)
Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes.
C. Zhang (2001)
10.1016/J.CARPATH.2006.09.001
Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis.
J. C. Russell (2006)
10.1210/ER.2003-0012
Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.
Z. Fang (2004)
10.1093/cvr/cvr076
Gain of function of cardiac ryanodine receptor in a rat model of type 1 diabetes.
C. Tian (2011)
10.1007/s00125-006-0263-y
Anaplerosis via pyruvate carboxylase is required for the fuel-induced rise in the ATP:ADP ratio in rat pancreatic islets
U. Fransson (2006)
10.2337/DIABETES.54.6.1829
Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy.
L. Cai (2005)
10.1161/CIRCULATIONAHA.105.554360
Reduced Mitochondrial Oxidative Capacity and Increased Mitochondrial Uncoupling Impair Myocardial Energetics in Obesity
S. Boudina (2005)
10.1016/0002-9149(72)90595-4
New type of cardiomyopathy associated with diabetic glomerulosclerosis.
S. Rubler (1972)
10.1152/AJPHEART.00559.2004
Redox regulation of Ito remodeling in diabetic rat heart.
Xun Li (2005)
10.1074/JBC.C200575200
Ghrelin Can Bind to a Species of High Density Lipoprotein Associated with Paraoxonase*
N. Beaumont (2003)
10.2337/DIABETES.50.6.1302
Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action.
C. Chan (2001)
10.1038/35007534
Central nervous system control of food intake
M. Schwartz (2000)
GH responses to GHRH and GHRP-6 in Streptozotocin (STZ)-diabetic rats.
Yolanda Diz Chaves (2003)
10.1289/EHP.01109S127
Molecular and cellular mechanisms of cardiotoxicity.
Y. J. Kang (2001)
10.1016/0022-2828(92)91098-P
Action potentials and potassium currents in rat ventricular muscle during experimental diabetes.
J. Magyar (1992)
10.1111/j.1365-2826.1989.tb00112.x
The Effects of a Growth Hormone‐Releasing Peptide and Growth Hormone‐Releasing Factor in Conscious and Anaesthetized Rats
R. G. Clark (1989)
10.1038/35051587
A role for ghrelin in the central regulation of feeding
M. Nakazato (2001)
10.1016/j.regpep.2005.04.004
Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice
Tetsuo Tsubone (2005)
10.1016/s0021-9258(18)42202-8
Hexose metabolism in pancreatic islets. Ca(2+)-dependent activation of the glycerol phosphate shuttle by nutrient secretagogues.
A. Sener (1992)
10.1038/415198a
Cardiac excitation–contraction coupling
D. Bers (2002)
10.1210/JCEM.86.7.7694
Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor.
R. Gondo (2001)
10.1210/en.2009-1432
Effects of GH secretagogues on contractility and Ca2+ homeostasis of isolated adult rat ventricular myocytes.
Qiang Sun (2010)
10.1161/01.RES.84.7.752
Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice.
A. Leri (1999)
10.1016/S0008-6363(01)00446-1
Up-regulation of K(+) channels in diabetic rat ventricular myocytes by insulin and glutathione.
Z. Xu (2002)
10.1677/JOE.1.06501
Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
E. Kim (2006)
10.1371/journal.pone.0035265
Growth Hormone Secretagogues Protect Mouse Cardiomyocytes from in vitro Ischemia/Reperfusion Injury through Regulation of Intracellular Calcium
Y. Ma (2012)
10.1046/j.1365-2443.1998.00223.x
Role of Bcl‐2 family proteins in apoptosis: apoptosomes or mitochondria?
Y. Tsujimoto (1998)
Ponery, Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats
E. Adeghate (2002)
10.1038/cdd.2010.105
Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to β-cell apoptosis
F. Allagnat (2011)
10.1152/ajpheart.00257.2011
Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat.
Xiangbin Xu (2012)
10.1111/J.0954-6820.1969.TB01511.X
Abnormal growth hormone response to ingestion of glucose in juvenile diabetics.
H. Yde (1969)
10.1161/01.RES.0000266449.37396.1F
Recipes for creating animal models of diabetic cardiovascular disease.
W. Hsueh (2007)
10.1152/PHYSREV.1994.74.1.139
Cellular defenses against damage from reactive oxygen species.
B. Yu (1994)
10.1073/PNAS.95.9.4997
Bax directly induces release of cytochrome c from isolated mitochondria.
J. Jürgensmeier (1998)
10.1016/0303-7207(92)90150-5
Study of hexose transport, glycerol phosphate shuttle and Krebs cycle in islets of adult rats injected with streptozotocin during the neonatal period
M. Giroix (1992)
10.1152/AJPHEART.1996.271.5.H2154
Intracellular protons inhibit transient outward K+ current in ventricular myocytes from diabetic rats.
Z. Xu (1996)
10.1152/AJPHEART.1991.260.2.H341
Influence of experimental diabetes on sarcoplasmic reticulum function in rat ventricular muscle.
R. Bouchard (1991)
10.1084/JEM.186.1.25
The Central Executioner of Apoptosis: Multiple Connections between Protease Activation and Mitochondria in Fas/APO-1/CD95- and Ceramide-induced Apoptosis
S. Susin (1997)
10.1038/345618A0
Kinetics, stoichiometry and role of the Na–Ca exchange mechanism in isolated cardiac myocytes
L. M. Crespo (1990)
10.1159/000126161
Effect of diabetes on in vivo and in vitro hypothalamic somatostatin release.
P. Joanny (1992)
10.1196/annals.1372.003
Blockade of the Renin–Angiotensin System Attenuates Sarcolemma and Sarcoplasmic Reticulum Remodeling in Chronic Diabetes
X. Liu (2006)
10.1016/J.ACTHIS.2006.07.002
A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice.
R. Coleman (2006)
10.1074/jbc.M109.024323
Transient Oxidative Stress Damages Mitochondrial Machinery Inducing Persistent β-Cell Dysfunction*
N. Li (2009)
10.1016/J.JACC.2005.09.030
Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus.
P. Herrero (2006)
10.1016/0092-8674(95)90235-X
Transgenic knockouts reveal a critical requirement for pancreatic β cell glucokinase in maintaining glucose homeostasis
A. Grupe (1995)
10.1016/S0022-0736(68)80005-6
Effects of some inhibitors of ionic permeabilities on ventricular action potential and contraction of rat and guinea-pig hearts.
E. Coraboeuf (1968)
10.1385/ENDO:29:1:135
Effects of gender difference on cardiac myocyte dysfunction in streptozotocin-induced diabetic rats
Y. Ding (2007)
10.1210/JCEM.86.10.8098
Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.
F. Broglio (2001)
10.1210/EN.2003-0723
Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes.
M. Malagón (2003)
10.1007/s12020-012-9623-1
A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy
Xinli Zhang (2012)
10.1161/01.CIR.0000072789.89096.10
Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes
Michaela Scheuermann-Freestone (2003)
10.1038/cdd.2009.165
The role of perforin and granzymes in diabetes
H. Thomas (2010)
10.1677/JOE.1.06241
Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice.
F. Dong (2006)
10.1159/000125338
Characterization of the glucose-dependent release of growth hormone-releasing factor and somatostatin from superfused rat hypothalami.
M. Baes (1990)
10.1016/j.ejps.2011.02.005
Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats.
Tingting Wu (2011)
10.1016/j.peptides.2012.06.020
Ghrelin protects against cobalt chloride-induced hypoxic injury in cardiac H9c2 cells by inhibiting oxidative stress and inducing autophagy
Xinxin Tong (2012)
10.1016/S0300-483X(97)00151-0
The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines.
G. Malich (1997)
10.1161/01.RES.87.12.1123
Myocardial Cell Death in Human Diabetes
A. Frustaci (2000)
The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure.
V. Roelfsema (2001)
10.1016/S0008-6363(99)00372-7
Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways.
G. Feuerstein (2000)
10.1210/ENDO-124-6-2791
The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture.
K. Cheng (1989)
10.1089/ARS.2007.9.49
Mechanisms of cell death in oxidative stress.
S. Ryter (2007)
10.1002/CLC.4960230513
Influence of autonomic neuropathy upon left ventricular dysfunction in insulin‐dependent diabetic patients
Patricia T. Monteagudo (2000)
10.1055/S-2007-996296
Association between serum insulin, serum somatomedin and liver receptors for human growth hormone in streptozotocin diabetes.
R. Baxter (1980)
10.2337/db12-0009
NADPH Oxidase NOX2 Defines a New Antagonistic Role for Reactive Oxygen Species and cAMP/PKA in the Regulation of Insulin Secretion
N. Li (2012)
10.1530/ACTA.0.1220001
Growth hormone in type I diabetic and healthy man.
N. Schaper (1990)
10.1152/AJPENDO.00517.2006
Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts.
S. Jesmin (2007)
10.1016/S1097-2765(01)00203-9
Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells.
B. Leibiger (2001)
10.1159/000126163
Hypothalamic regulation of impaired growth hormone secretion in diabetic rats. 1. Studies in streptozotocin-induced diabetic rats.
J. Ndon (1992)
10.1016/0304-4157(95)00003-A
The mitochondrial permeability transition.
M. Zoratti (1995)
10.1007/s007020050130
Streptozotocin increases free fatty acids and decreases phospholipids in rat brain
D. Müller (1998)
10.1152/AJPHEART.00683.2005
Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion.
J. Kim (2006)
10.2337/DIABETES.55.03.06.DB05-1039
Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy.
X. Shen (2006)
10.2337/db07-0291
Stromal Cell–Derived Factor-1 (SDF-1)/CXCL12 Attenuates Diabetes in Mice and Promotes Pancreatic β-Cell Survival by Activation of the Prosurvival Kinase Akt
T. Yano (2007)
10.1016/0140-6736(92)91768-4
Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young
G. Velho (1992)
10.1152/PHYSREV.1979.59.3.527
Hydroperoxide metabolism in mammalian organs.
B. Chance (1979)
10.1007/978-1-4615-6353-2_16
Fura-2 fluorescent technique for the assessment of Ca2+ homeostasis in cardiomyocytes
Yan-Jun Xu (1997)
10.1016/j.regpep.2009.03.003
Ghrelin inhibits apoptosis induced by high glucose and sodium palmitate in adult rat cardiomyocytes through the PI3K-Akt signaling pathway
L. Kui (2009)
10.1210/ENDO-123-5-2230
Impaired suppression of growth hormone release by somatostatin in cultured adenohypophyseal cells of spontaneously diabetic BB/W rats.
J. Welsh (1988)
10.1152/ajpendo.00112.2013
Overexpression of intraislet ghrelin enhances β-cell proliferation after streptozotocin-induced β-cell injury in mice.
Mika Bando (2013)
10.2337/db07-0075
Free Fatty Acid–Induced Reduction in Glucose-Stimulated Insulin Secretion
A. Oprescu (2007)
10.1210/EDRV-8-2-115
Effect of growth hormone on carbohydrate and lipid metabolism.
M. B. Davidson (1987)
10.1046/j.1365-2826.2002.00810.x
Ghrelin Acts on Leptin‐Responsive Neurones in the Rat Arcuate Nucleus
M. Traebert (2002)
10.1161/CIRCULATIONAHA.106.679597
Diabetic cardiomyopathy revisited.
S. Boudina (2007)
10.2337/DIABETES.50.2.227
Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.
M. Shintani (2001)
10.1681/ASN.2008050514
RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.
M. Coughlan (2009)
10.1161/01.CIR.0000012467.61045.87
Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms
M. Young (2002)



Semantic Scholar Logo Some data provided by SemanticScholar